News Inno-Gene S.A.

Equities

IGN

PLINNGN00015

End-of-day quote Warsaw S.E. Other stock markets 23:00:00 14/05/2024 BST			5-day change	1st Jan Change
1.76 ^PLN	0.00%		-1.68%	-20.00%

02-14	Inno-Gene S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
02-14	Inno-Gene S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Inno-Gene S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-14	CI
Inno-Gene S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	02-14	CI
Inno-Gene S.A. announced that it expects to receive PLN 1 million in funding	01-10	CI
Inno-Gene S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
Inno-Gene S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
Inno-Gene S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Inno-Gene S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	07/02/23	CI
Inno-Gene S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	07/02/23	CI
Inno-Gene S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22	CI
Ignitis to Secure $119 Million Credit Line to Bolster Capital Amid Higher Energy Prices	25/10/22	MT
Naturativ Sp. z o.o. announced that it has received PLN 0.49995 million in funding from Inno-Gene S.A.	17/08/22	CI
Inno-Gene S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/08/22	CI
Inno-Gene S.A. acquired additional 10.72% minority stake in Naturativ for PLN 0.01 million.	31/05/22	CI
Inno-Gene S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22	CI
Ignitis Expects Debt Repayment, Compensation as Lithuania Enacts Anti-Inflation Measures	04/04/22	MT
Inno-Gene S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	14/02/22	CI
Inno-Gene S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	14/02/22	CI
Ignitis Grupé Unit Acquires Wind Farm in Poland	21/12/21	MT
Ignitis Secures Polish License to Operate Wind Farm	07/12/21	MT
Inno-Gene S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12/11/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Inno-Gene S.A.

Equities

IGN

PLINNGN00015

Summary

Filters